Baxalta

OBIZUR

Manufacturer:

Baxalta

Obizur HCPCS:

J7188

HCPCS Code Descriptor:

Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.

Category:

J Code

Obizur NDCs:

00944-5001-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Obizur CPT Codes:

Potential CPT administration codes for Obizur can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Obizur:

OBIZUR is a Hematology drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J7188 is aligned to the drug OBIZUR.

ACCESS PRICING AND MORE BY REGISTERING

J7188 Added Date:

January 1, 2016

J7188 Effective Date:

January 1, 2016

J7188 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Obizur billing and coding information.
Obizur patient assistance information can be found through Takeda Patient Support at the URL: https://www.hematologysupport.com/financial-assistance#about-pap
OBIZUR prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for OBIZUR. Please check back in a few weeks.